Related Experiment Video
Updated: Jul 16, 2026

Manipulation and Analysis of Cell Cycle-Dependent Processes in Budding Yeast
Published on: September 26, 2025
Rapamycin-mediated G1 arrest involves regulation of the Cdk inhibitor Sic1 in Saccharomyces cerevisiae
Vittoria Zinzalla1, Michele Graziola, Andrea Mastriani
1Department of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126, Milano, Italy.
Abstract:
The rapamycin-sensitive (TOR) signalling pathway in Saccharomyces cerevisiae controls growth and cell proliferation in response to nutrient availability. Rapamycin treatment causes cells to arrest growth in G1 phase. The mechanism by which the inhibition of the TOR pathway regulates cell cycle progression is not completely understood. Here we show that rapamycin causes G1 arrest by a dual mechanism that comprises downregulation of the G1-cyclins Cln1-3 and upregulation of the Cdk inhibitor protein Sic1. The increase of Sic1 level is mostly independent of the downregulation of the G1 cyclins, being unaffected by ectopic CLN2 expression, but requires Sic1 phosphorylation of Thr173, because it is lost in cells expressing Sic1(T173A). Rapamycin-mediated Sic1 upregulation involves nuclear accumulation of a more stable, non-ubiquitinated protein. Either SIC1 deletion or CLN3 overexpression results in non-cell-cycle-specific arrest upon rapamycin treatment and makes cells sensitive to a sublethal dose of rapamycin and to nutrient starvation. In conclusion, our data indicate that Sic1 is involved in rapamycin-induced G1 arrest and that deregulated entrance into S phase severely decreases the ability of a cell to cope with starvation conditions induced by nutrient depletion or which are mimicked by rapamycin treatment.
Insights
Rapamycin treatment halts yeast cell growth by downregulating G1-cyclins and increasing the Sic1 protein, a dual mechanism essential for nutrient starvation survival.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- The nutrient-sensing target of rapamycin (TOR) pathway regulates yeast growth and proliferation.
- Rapamycin inhibits TOR signaling, leading to G1 cell cycle arrest, but the precise mechanism remains unclear.
Purpose of the Study:
- To elucidate the molecular mechanisms by which TOR inhibition by rapamycin induces G1 cell cycle arrest in Saccharomyces cerevisiae.
- To investigate the roles of G1-cyclins and the Cdk inhibitor Sic1 in this process.
Main Methods:
- Rapamycin treatment of Saccharomyces cerevisiae.
- Analysis of G1-cyclin (Cln1-3) levels.
- Assessment of Cdk inhibitor protein Sic1 levels and phosphorylation.
- Investigation of Sic1 nuclear localization and ubiquitination.
- Gene deletion and overexpression studies (SIC1, CLN2, CLN3).
Main Results:
- Rapamycin induces G1 arrest via a dual mechanism: downregulation of G1-cyclins (Cln1-3) and upregulation of Sic1.
- Sic1 upregulation is largely independent of G1-cyclin downregulation but requires Sic1 phosphorylation at Thr173.
- Rapamycin promotes Sic1 nuclear accumulation, stabilizing the protein by preventing ubiquitination.
- SIC1 deletion or CLN3 overexpression leads to non-cell-cycle-specific arrest and increased sensitivity to rapamycin and nutrient starvation.
Conclusions:
- Sic1 plays a crucial role in rapamycin-induced G1 arrest.
- Dysregulated entry into S phase compromises cellular ability to withstand nutrient starvation conditions mimicked by rapamycin.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Negative Regulator Molecules
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
The Cell Cycle Control System
Positive Regulator Molecules

